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Background: Bronchopulmonary dysplasia is one of the main complications associated with extreme pre-
maturity. Oxidative stress is suspected to be a trigger event of this lung disease, which is characterized
by impaired alveolar development. Peroxides, mainly ascorbylperoxide and H 2 O 2 , are known contaminant
of parenteral nutrition. We hypothesize that these oxidant molecules induce bronchopulmonary dysplasia
development. The aim was to determine if the infusion of ascorbylperoxide, whether in presence or absence
of H 2 O 2 , is associated with oxidative stress, apoptosis and loss of alveoli in the lungs of newborn guinea pigs.
Method: Three-day-old guinea pigs received parenteral solutions containing 0, 20, 60 or 180 μM ascor-
bylperoxide in the presence or not of 350 μM H 2 O 2 (concentrations similar to those measured in parenteral
nutrition). After 4 days, the lungs were collected for determination of glutathione’s redox potential, caspase-3
activation (an apoptosis marker), alveolarization index (by histology), activation of Nrf2 and NF κB (biological
markers of oxidative stress), and IL-6 and PGJ 2 levels (markers of NF κB activation). Groups were compared
by ANOVA, p < 0.05. 
Results: Loss of alveoli was associated with ascorbylperoxide in a dose-dependent manner, without an
inﬂuence of H 2 O 2 . The dose-dependent activation of caspase-3 by ascorbylperoxide was lower in the presence
of H 2 O 2 . Ascorbylperoxide induced an increase of redox potential in a dose-dependent manner, which reached
a plateau in presence of H 2 O 2 . Nrf2 and NF κB were activated by H 2 O 2 but not by ascorbylperoxide. 
Conclusion: Results suggest that ascorbylperoxide, generated in parenteral nutrition, is involved in the
development of bronchopulmonary dysplasia, independently of the increase of the redox potential. This
study underlines the importance of developing a safer formulation of parenteral nutrition. 
c © 2014 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Decreased alveolar number and impaired vascular development
are characteristic features of bronchopulmonary dysplasia (BPD) [ 1 , 2 ].
Extremely premature infants ( < 29 weeks of gestation) are affected
by BPD in 50% of cases. Amongst the multiple consequences of BPD,
lung function impairment, which can persist until adulthood [ 3 –5 ],
and altered neurodevelopment are the most worrisome [ 6 , 7 ]. Re-
quirement in oxygen supplementation, with its associated oxidative
stress, has long been recognized as a component in the aetiology of
BPD [ 1 , 2 , 8 ]. Recently, parenteral nutrition (PN) has been suggested to
play an important role in BPD development. It has been reported that
peroxides, which contaminate PN, induce oxidative stress in newborn* Correspondence to: Research Centre, CHU Sainte-Justine, 3175 Chemin de la C ˆ ote 
Ste-Catherine, Montreal, QC, Canada H3T 1C5. 
E-mail address: jean-claude.lavoie@umontreal.ca (J.c. Lavoie). 
 
 
 
2213-2317/ $ - see front matter c © 2014 The Authors. Published by Elsevier B.V. This is an
licenses / by-nc-nd / 3.0 / ). 
http://dx.doi.org/10.1016/j.redox.2014.05.002 animals [ 9 ] as well as in premature infants [ 10 ]. Light-protection of PN
reduces by half the peroxide generation in intravenous solution [ 10 –
12 ], decreases the incidence of BPD [ 13 ] and chronic lung diseases
[ 12 ] in premature infants and prevents the alveolar loss in newborn
guinea pigs [ 14 ]. An animal study by Lavoie et al. [ 15 ] reported that
an exaggerated apoptosis is associated with the loss of alveoli, inde-
pendently of the H 2 O 2 level present in PN. This study also described
that the loss of alveoli is reproduced by the infusion of a solution con-
taining vitamin C and riboﬂavin, components found in PN. Interaction
between these two vitamins, in presence of ambient light, generates a
new organic peroxide derived from the peroxidation of dehydroascor-
bate by H 2 O 2 [ 16 , 17 ]. We suspect that this molecule (2,3-diketo-4-
hydroxyperoxyl-5,6-dihydroxyhexanoic acid), named in the current
report as “ascorbylperoxide”, participates in the development of BPD. 
Peroxides are detoxiﬁed by the glutathione metabolism, in which
GSH is oxidized into GSSG. The concentration of both forms of glu-
tathione impacts on the cellular redox environment. Because cell open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 
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Fig. 1. Inﬂuence of ascorbylperoxide and H 2 O 2 on the urine concentration of ascor- 
bylperoxide. The level of ascorbylperoxide in urine increased ( ** 0 vs. 20, 60,180 μM; 
p < 0.01) linearly in function of the received dose of ascorbylperoxide ( # between 20, 
60 and180 μM; p < 0.01) and was lower in groups infused with solutions containing 
H 2 O 2 (with vs. without H 2 O 2 ; p < 0.05). Mean ± S.E.M.; n = 4–7. ycle (proliferation, differentiation and apoptosis) is inﬂuenced by 
he redox environment [ 18 ], the presence of peroxides in PN can in- 
uce arrest of pulmonary development or even apoptosis. Chessex 
t al. [ 19 ] have recently reported that the level of redox potential 
f glutathione measured in blood of premature infants was strongly 
orrelated with the severity of BPD [ 19 ]. We hypothesize that ascor- 
ylperoxide infused with PN induces oxidative stress characterized 
y a higher redox potential, which stimulates apoptosis and leads to 
lveolar loss. Therefore, the aim of this study was to document that 
he infusion of increasing concentrations of ascorbylperoxide is asso- 
iated with an elevation of redox potential of glutathione, activation 
f an apoptosis marker and a reduced number of alveoli in the lungs 
f newborn guinea pigs. Because PN contains also H 2 O 2 , which can 
otentially exacerbate the oxidation of glutathione, the intravenous 
olutions infused to animals in this study will contain or not H 2 O 2 
ascorbylperoxide ± H 2 O 2 ). 
aterials and methods 
Sixty Hartley guinea pigs (Charles River Laboratories, Saint- 
onstant, Quebec, Canada) have been used in eight groups (6–9 ani- 
als per group). At 3 days of life, a catheter (SAI Infusion Technolo- 
ies, Lake Villa, IL) was ﬁxed in the right jugular vein as previously 
escribed [ 13 , 14 , 20 ] to inject the experimental intravenous solutions 
reshly prepared each day. The solutions, which were continuously 
nfused at a rate of 19 mL / 100 g / d [ 21 ], contained: 8.7% (w,v) dex-
rose + 0.3% (w,v) NaCl + 1 U / mL heparin + 0, 20, 60 or 180 μM 
scorbylperoxide ± 350 μM H 2 O 2 (concentrations previously mea- 
ured in total parenteral nutrition) [ 11 , 14 ]. A usual total parenteral 
utrition containing 1% of a multivitamin preparation (Multi-12 pae- 
iatric, Sandoz, Boucherville, QC, Canada) generates 36 ± 1 μM ascor- 
ylperoxide (J.C. Lavoie, personal communication). Because ascor- 
ylperoxide does not commercially exist, it was generated in vitro , 
s previously described [ 21 ]. After 4 days of infusion, lungs were col- 
ected as per the protocol previously explained in references (14) and 
15). The right lung was used for biochemical measurements and the 
eft one was used for histology. Urine was collected directly from the 
ladder for determination of ascorbylperoxide concentration. Forty- 
ight animals had urine in their bladder at the time of sacriﬁce. The 
rotocols were approved by the Institutional Committee for Good 
ractice with Animals in Research, in accordance with the Canadian 
ouncil of Animal Care guidelines. 
Alveolarization index represents the mean value for each animal of 
he number of intercepts between a standardized straight-line (1 mm) 
nd histological structures calculated from four different ﬁelds of the 
ame lung (200 × magniﬁcation) [ 14 , 15 ]. 
Ascorbylperoxide concentration in intravenous solutions, as well 
s in urine, was quantiﬁed by using an LC / MS methodology pre- 
iously described [ 16 , 21 ]. Because the internal standard was L-2- 
xothiazolidine-4-carboxylate (OTC), results are expressed in OTC 
quivalent. 
Glutathione (GSH and GSSG) was determined by capillary elec- 
rophoresis, as previously described [ 20 –22 ], whereas the redox po- 
ential was calculated (25 ◦C, pH 7) by using the Nernst equation. 
Apoptosis was deﬁned by calculating the proportion of active 
cleaved caspase-3) on total caspase-3 (cleaved + non-cleaved). 
hese two forms of the protein were quantiﬁed by Western blot as 
escribed in [ 22 ]. 
rf2 and NF κB: In order to qualify the oxidative stress, in addition to glu- 
athione redox state, protein levels of Nrf2 and NF κB have also been mea- 
ured. Nrf2 is a nuclear factor involving antioxidant defences. It favours 
he transcription of genes encoding for, among others, glutathione syn- 
hesis. NF κB is a nuclear factor favouring inﬂammation. Determination 
y Western blot [ 23 ] of their cytosolic level and nuclear fraction, using a commercially nuclear and cytoplasmic extraction kit (Pierce Biotech- 
nology, Rockford, IL, USA), allowed calculation of the proportion present 
in the nucleus (active form). They were reported as activated protein 
(nuclear level / nuclear + cytosolic levels). The Western blot method de- 
scribed by H u¨bner et al. [ 23 ] was used, except for the antibody against 
NF κB, for which we have used the MaxPab mouse polyclonal NF κB an- 
tibody from Abnova (Taipei, Taiwan). IL-6 and PGJ 2 : From lung ho- 
mogenate (1 in 4 volume of water), concentration of IL-6 was eval- 
uated by the Human IL-6 ELISA kit (Anogen Mississauga, Ontario) 
whereas the 15-deoxy- 12,14 -PGJ 2 EIA kit (Enzo, Plymouth, PA, USA) 
was used to measure PGJ 2 levels after a C-18 extraction [ 24 ]. 
Statistical analysis 
Data from each group are presented as mean ± S.E.M., and have 
been compared by factorial ANOVA (4 concentrations of ascorbylper- 
oxide × H 2 O 2 ). All comparisons were orthogonal. To meet the ho- 
moscedasticity, which was veriﬁed by using Bartlett ’ s Chi squared 
test, data for GSH, Nfr2 and NF κB have been logarithmically trans- 
formed. The level of signiﬁcance was set at p -value < 0.05. Comparison 
between groups receiving the solutions devoid of ascorbylperoxide 
and groups infused with the three concentrations of this peroxide was 
used to statistically document the effect of ascorbylperoxide. The use 
of coefﬁcients for linear and quadratic polynomials allowed analysis 
of the dose–response effect of ascorbylperoxide. A signiﬁcant interac- 
tion between H 2 O 2 and ascorbylperoxide led us to analyze the impact 
of ascorbylperoxide separately of the presence or absence of H 2 O 2 . 
Results 
There was no statistical difference between initial mean body 
weight among groups (104 ± 2 g ( n = 60); H 2 O 2 effect: F (1,52) < 0.1; 
ascorbylperoxide effect: F (3,52) = 1.3). The urinary concentration of 
ascorbylperoxide ( Fig. 1 ) increased ( F (1,40) = 12.6, p < 0.01) linearly 
( F (1,40) = 37.3, p < 0.01) in function of the dose of ascorbylperoxide 
received and was 25% lower in animals infused with solutions con- 
taining H 2 O 2 ( F (1,40) = 5.9, p < 0.05). The total amount of intravenous 
solution received was similar ( F (1,40) = 0.3) in the group receiving 
H 2 O 2 (72.3 ± 1.3 mL) and in the group without H 2 O 2 (71.9 ± 0.8 mL). 
The ANOVA revealed a signiﬁcant interaction between ascor- 
bylperoxide and H 2 O 2 ( F (3,49) = 3.1, p < 0.05) on the redox poten- 
tial of glutathione in the lungs ( Fig. 2 A). In the absence of H 2 O 2 , 
the ascorbylperoxide has induced an increase of the redox poten- 
tial ( F (1,49) = 7.7, p < 0.01) that was linearly dependent on the dose 
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Fig. 2. Inﬂuence of ascorbylperoxide and H 2 O 2 on the redox potential of glutathione 
and GSH level in lungs. Due to the signiﬁcant interaction ( p < 0.05) between ascor- 
bylperoxide and H 2 O 2, the effects of the ascorbylperoxide on the redox potential and 
on GSH have been analyzed according to the presence or not of H 2 O 2 . (A) In absence of 
H 2 O 2 , the redox potential was lower in the group devoid of ascorbylperoxide ( 
** 0 vs. 20, 
60,180 μM; p < 0.01). The impact of the ascorbylperoxide was linearly dose-dependent 
( # between 20, 60 and180 μM; p < 0.05). There was no modiﬁcation of redox potential 
by the ascorbylperoxide in animals infused with solution containing H 2 O 2 . (B) In ab- 
sence of H 2 O 2 , the GSH level was higher in the group devoid of ascorbylperoxide ( 
** 0 
vs. 20, 60,180 μM; p < 0.01). The impact of the ascorbylperoxide was independent of 
the dose (no difference between 20, 60 and180 μM). There was no modiﬁcation of the 
GSH value in animals infused with solution containing H 2 O 2 . Mean ± S.E.M.; n = 6–9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Inﬂuence of ascorbylperoxide and H 2 O 2 on the activated caspase-3. The level of 
activated caspase-3 was increased ( ** 0 vs. 20, 60,180 μM; p < 0.01) linearly in function 
of the received dose of ascorbylperoxide ( # between 20, 60 and180 μM; p < 0.05) and 
was lower in groups infused with solutions containing H 2 O 2 (with vs. without H 2 O 2 ; 
p < 0.01). Mean ± S.E.M.; n = 4–7. 
Fig. 4. Inﬂuence of ascorbylperoxide and H 2 O 2 on cleaved and non-cleaved caspase-3. 
(A) Representative examples ( n = 3 per group) of Western blot obtained for the cleaved 
and non-cleaved caspase-3, relatively to tubulin. (B) The level of cleaved caspase-3 
was lower in groups devoid of ascorbylperoxide ( ** 0 vs. 20, 60,180 μM; p < 0.01) 
but increased linearly in function of the dose of ascorbylperoxide ( # between 20, 60 
and180 μM; p < 0.05). The level of cleaved caspase-3 was not affected by the presence 
of H 2 O 2 . (C) Non-cleaved caspase-3 was not affected by ascorbylperoxide or H 2 O 2 , with 
exception of the 180 μM ascorbylperoxide group ( p < 0.05). Mean ± S.E.M.; n = 6–10. 
 
 
 
 
 
 ( F (1,49) = 4.4 p < 0.05), whereas in presence of H 2 O 2 the redox po-
tentials were not inﬂuenced by ascorbylperoxide ( F (3,49) = 0.7). The
mean value of redox in H 2 O 2 groups was of −203 ± 1 mV ( n = 28).
This value was similar to the one measured in the groups 60 and
180 μM ascorbylperoxide without H 2 O 2 . The modiﬁcation in redox
potential was caused by modiﬁcation in GSH rather than a change
in GSSG value. Indeed, there was no modiﬁcation in GSSG levels be-
tween groups (0.61 ± 0.03 nmol / mg prot, n = 57) whereas a signif-
icant interaction ( F (1,49) = 4.0 p < 0.05) between ascorbylperoxide
and H 2 O 2 was observed for GSH values ( Fig. 2 B). The level of GSH
was lower in the lung of animals infused with a solution containing
ascorbylperoxide or H 2 O 2 . The actions of these peroxides were not
additive (signiﬁcant interaction) and the effect of ascorbylperoxide
was not dose-dependent ( F (1,49) < 2.1) ( Fig. 2 B). 
Ascorbylperoxide and H 2 O 2 inﬂuenced the levels of activated
caspase-3 ( Fig. 3 ). The absence of signiﬁcant interaction ( F (3,52) = 1.0)
suggested an additive effect. In fact, data show that ascorbylperox-
ide was a linear dose-dependent ( F (1,53) = 5.3, p < 0.05) inducer
( F (1,53) = 24.7, p < 0.01), whereas H 2 O 2 had a 15% inhibitory effect
( F (1,53) = 11.3, p < 0.01). The activated caspase-3 is deﬁned as the ratio
of cleaved caspase-3 on the total caspase-3 (cleaved + non-cleaved)
( Fig. 4 ). Ascorbylperoxide ( p < 0.01) and H 2 O 2 ( p < 0.05) had a simi-
lar impact on cleaved caspase-3 and on activated caspase-3 whereas
they did not inﬂuence the level of the non-cleaved enzyme. The low
level of non-cleaved caspase-3 in the group 180 μM ascorbylperoxide
without H 2 O 2 remains without explanation. Despite the negative impact of H 2 O 2 on the apoptosis marker
( Fig. 3 ), the alveolarization index ( Fig. 5 A) was inﬂuenced only by
ascorbylperoxide ( F (1,47) = 6.8, p < 0.05), not by H 2 O 2 ( F (1,47) = 0.1),
without interaction ( F (3,47) = 0.6). The decreasing in alveolariza-
tion index responded to a linear dose-effect of ascorbylperoxide
( F (1,47) = 9.0, p < 0.01). Examples of histology of lungs are shown
in Fig. 5 B. 
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Fig. 5. Inﬂuence of ascorbylperoxide and H 2 O 2 on alveolarization index. (A) The 
alveolarization index was higher in groups devoid of ascorbylperoxide (**0 vs. 20, 
60,180 μM; p < 0.05). The impact of the ascorbylperoxide was linearly dose-dependent 
( # between 20, 60 and180 μM; p < 0.01). The alveolarization index was not affected 
by the presence of H 2 O 2 . (B–E) representative examples of histological pictures of 
lungs from animals infused with a solution (B) devoid of H 2 O 2 and of ascorbylperox- 
ide, (C) containing 350 μM H 2 O 2 without ascorbylperoxide, (D) containing 180 μM 
ascorbylperoxide without H 2 O 2 , or (E) containing 350 μM H 2 O 2 and 180 μM ascor- 
bylperoxide. The alveolarization index is based on the number of histological structures 
crossing the calibrated (1 mm) line. Mean ± S.E.M.; n = 6–10. 
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Fig. 6. Inﬂuence of ascorbylperoxide and H 2 O 2 on the activated NFkB and Nrf2 in lungs. 
Activation of NFkB (A) and of Nrf2 (B) were lower on groups without ascorbylperoxide 
( ** 0 vs. 20, 60,180 μM; p < 0.01). However, the impact of ascorbylperoxide was without 
dose-effect (no difference between 20, 60 and180 μM). There was an additive effect of 
H 2 O 2 ( p < 0.01) on activation of both factors. Mean ± S.E.M.; n = 6–8. 
Fig. 7. Representative examples of Western blot results for NFkB and Nrf2 determined 
in cytosol and nucleus. Three examples of Western blot results (relative to tubulin) for 
each group of animals infused with 0–180 μM ascorbylperoxide ± 350 μM H 2 O 2 on 
the nuclear (A) and cytosolic fraction (B) of Nrf2 and NFkB in lungs. Full data are shown 
in Fig. 8 -9. Due to the difference in effect between both peroxides on alveo- 
arization index, a doubt persisted on the value of the observed re- 
ox potentials and on the real oxidative capacity of each peroxide 
nfused during the 4 days of the experiment. Thus, biological mark- 
rs of oxidative stress, such as NF κB and Nrf2, were measured. Both 
eroxides were associated with a similar impact on activated NF κB 
nd Nrf2 ( Fig. 6 A and B, respectively). Their levels were higher in 
nimals receiving H 2 O 2 ( F (1,49) = 14.9, p < 0.01) and ascorbylperox- 
de ( F (1,49) = 8.2, p < 0.01), without a dose-effect ( F (1,49) = 1.0). The 
nteractions did not reach statistical signiﬁcance ( F (3,49) = 1.8). 
Examples ( n = 3 for each group) of Western blot of proteins mea- 
ured in cytosolic and nuclear fractions are shown in Fig. 7 . Complete 
alues are reported in Figs. 8 and 9 . NF κB levels in nucleus ( Fig. 8 A)
nd in cytosol ( Fig. 8 B) were higher in animals infused with solutions 
ontaining ascorbylperoxide ( F (1,49) = 4.9, p < 0.05), independently 
f the presence of H 2 O 2 (no interaction, F (3,49) = 2.8). The effect of 
scorbylperoxide was without dose-effect ( F (1,49) = 2.0). NF κB was 
ower in the cytosolic fractions of lungs from animals infused with 
olution containing H 2 O 2 ( F (1,49) = 23.1, p < 0.01). H 2 O 2 had no effect 
n values in nucleus ( F (1,49) = 1.5). 
In the nucleus, the interaction between peroxides for Nrf2 was 
igniﬁcant ( F (3,49) = 3.0, p < 0.05) ( Fig. 9 A). The levels of Nrf2 
ere higher in animals receiving solutions containing both perox- 
des ( F (1,49) = 9.1, p < 0.01) without dose-effect of ascorbylperoxide 
 F (1,49) = 3.9). Without H 2 O 2 , ascorbylperoxide was without signif- 
cant effect ( F (1,49) = 1.6). In the cytosol, the levels of Nrf2 were lower in animals infused with solutions containing H 2 O 2 ( F (1,49) = 4.5, 
p < 0.05), whereas ascorbylperoxide was without signiﬁcant effect 
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Fig. 8. Inﬂuence of ascorbylperoxide and H 2 O 2 on nuclear and cytosolic NFkB. (A) 
Nuclear levels of NFkB were lower on group without ascorbylperoxide ( ** 0 vs. 20, 
60,180 μM; p < 0.01). The impact of ascorbylperoxide was without dose-effect (no 
difference between 20, 60 and180 μM). The presence of H 2 O 2 had no impact on results. 
(B) Cytosolic levels of NFkB were lower on group without ascorbylperoxide ( * 0 vs. 20, 
60,180 μM; p < 0.05). The impact of ascorbylperoxide was without dose-effect (no 
difference between 20, 60 and180 μM). Cytosolic levels of NFkB were lower in presence 
of H 2 O 2 ( p < 0.01). Mean ± S.E.M.; n = 6–10. 
Fig. 9. Inﬂuence of ascorbylperoxide and H 2 O 2 on nuclear and cytosolic Nrf2. (A) Due 
to the signiﬁcant interaction ( p < 0.05) between ascorbylperoxide and H 2 O 2, the effects 
of the ascorbylperoxide on nuclear levels of Nrf2 have been analyzed according to the 
presence or not of H 2 O 2 . In absence of H 2 O 2 , there was no difference between groups. 
In presence of H 2 O 2 , the nuclear level of Nrf2 was lower in the group devoid of ascor- 
bylperoxide ( ** 0 vs. 20, 60,180 μM; p < 0.01). (B) Ascorbylperoxide was without effect 
on cytosolic Nrf2 levels whereas they were lower in animals infused with solutions 
containing H 2 O 2 ( p < 0.05). Mean ± S.E.M.; n = 6–10. 
 
 
 
 
 
 
 
Fig. 10. Inﬂuence of ascorbylperoxide and H 2 O 2 on PGJ 2 . Ascorbylperoxide was with- 
out effect on PGJ 2 levels whereas they were higher in animals infused with solutions 
containing H 2 O 2 ( p < 0.01). Mean ± S.E.M.; n = 6–10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 on Nrf2 levels ( F (1,49) = 2.0). There was no interaction between H 2 O 2
and ascorbylperoxide on the cytosolic Nrf2 levels ( F (3,49) = 0.9). 
The efﬁciency of activation of NF κB by peroxides was evalu-
ated by measuring two molecules derived from his activation. The
4-day exposure to the peroxides could induce inﬂammation. Thus,
IL-6 level (a pro-inﬂammatory marker) was measured, as well as
and PGJ 2 level (an anti-inﬂammatory marker). There was no sig-
niﬁcant effect on IL-6 (mean ± S.E.M. = 0.69 ± 0.06 pg / mg prot;F (1,20) < 3.9), whereas PGJ 2 levels ( Fig. 10 ) were higher in the H 2 O 2
groups ( F (1,51) = 9.4, p < 0.01). Ascorbylperoxide was without sig-
niﬁcant effect ( F (1,51) = 0.02) on PGJ 2 level. There was no signiﬁcant
interaction ( F (1,51) = 0.3). 
Discussion 
This study highlights the toxic effect of ascorbylperoxide, a by-
product of peroxidation of dehydroascorbate generated in the solu-
tion of parenteral nutrition, on the lungs of our animal model. After
4 days of infusion, this molecule has induced one of the main features
of BPD (a lower alveoli number), independently of the presence of
H 2 O 2 . 
Consistent with our hypothesis, this study demonstrated that
ascorbylperoxide has produced (1) an oxidation of the redox poten-
tial, (2) an activation of caspase-3, a marker of apoptosis, and (3) a
lower alveolarization index. The second part of the hypothesis was
that H 2 O 2 , a contaminant of parenteral nutrition, exacerbates the
oxidative stress and, consequently, inﬂuences the impact of ascor-
bylperoxide. Indeed, H 2 O 2 has induced an oxidation of the redox
potential that has reached a plateau. The mean redox value mea-
sured in animal infused with solutions containing H 2 O 2 was similar
to that observed in animals infused with solutions containing the two
greatest concentrations of ascorbylperoxide (without H 2 O 2 ). This ob-
servation suggests that the redox potential might not be the main
trigger of the apoptosis. Indeed, although the animals infused with
H 2 O 2 had the highest redox potential, independently of the presence
of ascorbylperoxide, the activation of caspase-3 by ascorbylperoxide
was lower by 15% in H 2 O 2 groups. Despite this negative effect of H 2 O 2
on caspase-3, the activation remained sufﬁcient to induce a decrease
in the alveolar number. The effect of ascorbylperoxide on alveolar-
ization index was similar to the values previously reported in studies
investigating the effect of parenteral nutrition [ 14 , 15 ]. 
The discrepancy between redox potential values and activation of
caspase-3, especially in H 2 O 2 groups, suggests that the modiﬁcation
of the redox potential could be not enough to induce biologically per-
tinent oxidative stress. The study of the impact of both peroxides on
the activation of NF κB and Nrf2 is instructive. The effects of ascor-
bylperoxide on redox potential, caspase-3 and alveolarization index
were linearly dependent to the dose infused. In contrast, the positive
impact of this peroxide on activation of NF κB and Nrf2 is not dose-
dependent and reached a plateau at the lowest concentration. The
levels of NF κB in cytosol and nucleus also reached a plateau, whereas
no activation of Nrf2 by ascorbylperoxide was documented in cytosol
and nucleus. One may question the relevance of the activation of NF κB
by ascorbylperoxide considering the absence of dose-effect between
those two molecules. Indeed, levels of IL-6 and PGJ 2 , two products
of this activation, were not affected by ascorbylperoxide. Thus, the
biological oxidative capacity of infused ascorbylperoxide in lungs is
730 W. Elremaly et al. / Redox Biology 2 (2014) 725–731 
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cimited. In addition, the action of ascorbylperoxide on redox potential 
f glutathione is linked to a lower level of GSH rather than elevation 
f GSSG, an oxidized form of glutathione. 
The statistically signiﬁcant effect of H 2 O 2 on activation of NF κB 
esulted from a lower level of NF κB in the cytosol rather than from a 
igher level in the nucleus. However, the activation is suggested by 
he positive impact of H 2 O 2 on PGJ 2 levels. Thus, in contrast to ascor- 
ylperoxide, the oxidative effect of infused H 2 O 2 is conﬁrmed by the 
ctivation of NF κB, the increase of PGJ 2 and the activation of Nrf2. The 
imilarity between the histogram of nuclear Nrf2, shown in Fig. 9 A, 
nd the results for PGJ 2 level ( Fig. 10 ) suggest that the activation of 
rf2 in H 2 O 2 groups is induced by PGJ 2 [ 25 ] rather than by the direct 
xidative property of H 2 O 2 . Thus, independently of its effects on the 
edox potential of glutathione, ascorbylperoxide seemed to be with- 
ut biological oxidative capacity in the lungs. Ascorbylperoxide has 
nduced alveolar loss following activation of caspase-3. H 2 O 2 exerted 
 biological oxidative stress, but without an effect on alveolarization 
ndex. Those results put into question the relation between oxidative 
tress and the effect of PN on BPD. 
From a previous report by our group, it is known that H 2 O 2 in- 
used with parenteral nutrition inhibits the hepatic pathway of trans- 
ormation of methionine into cysteine, of which the availability is a 
ate-limiting step in the glutathione synthesis [ 20 ]. This is in accor- 
ance with the current study in which the increase of redox potential 
f glutathione was related to a lower GSH rather than to a higher 
SSG. The inhibition of hepatic transformation of methionine by PN 
ontaining H 2 O 2 led to a lower glutathione concentration in liver and 
n blood [ 20 ]. Glutathione in blood circulation is an important source 
f substrates for the de novo cellular synthesis of GSH. Indeed, by- 
roducts of the γ-glutamyltranspeptidase action on the glutathione 
hat is in blood circulation are captured by the cell and are processed 
o a new synthesis of glutathione. A similar inhibition by ascorbylper- 
xide could also explain the lower level of GSH in lungs from animal 
nfused with ascorbylperoxide alone. 
The discrepancy between the positive effect of H 2 O 2 on Nrf2 and its 
egative effect (increase) on redox potential is surprising. Nrf2 is well 
nown to be the nuclear factor that favours a new synthesis of GSH 
 26 ]. The absence of concordance between them could be explained by 
 limiting availability of substrate, speciﬁcally cysteine, for the de novo 
ynthesis of glutathione. The experimental design involved the use of 
 solution containing only ascorbylperoxide ± H 2 O 2 , without amino 
cids or lipids. However, glucose was the only carbon substrate added 
s an energy source. The levels of glutathione in animals infused with 
hese solutions, which were devoid of substrates for GSH synthesis, 
anged from 21 to 33 nmol / mg prot ( Fig. 2 ). These levels were similar
16–23 nmol / mg prot) to those reported in a previous study where 
nimals received total parenteral nutrition that included amino acids 
 14 ]. Thus, in the present study, the GSH pool seems in equilibrium. 
ack of amino acids in nutrition of animals may still limit the de novo 
rotein synthesis following gene transcription. 
The association between the redox potential of glutathione (mea- 
ured in lungs from animals infused with solutions containing ascor- 
ylperoxide) and the alveolarization index is in accordance with the 
ssociation reported by Chessex et al. [ 19 ]. Indeed, the aforemen- 
ioned study described a relationship between the severity of BPD 
nd the redox potential of glutathione measured in whole blood of 
remature newborns. However, our results suggest that these two 
arameters are parallel events rather than being interconnected. The 
iscrepancy between pulmonary redox potential and alveolar count 
as already been reported in newborn guinea pigs infused with par- 
nteral nutrition, despite presence or absence of photo-protection 
 14 ]. 
Activation of caspase-3 leads to cleavage of cellular proteins, a 
rocess of irreversible apoptosis [ 27 ]. This protease is activated by 
aspase-8, caspase-9 or caspase-10. Following impairment of mito- 
hondria, cytochrome c is released and transforms the pro-caspase-9 in an active protease [ 28 ]. Caspases-8 and 10 are activated following 
stimulation of receptors such as Fas receptor or Tumour necrosis fac- 
tor receptor 1 [ 29 ]. The redox potential does not seem to play a key 
role in the activation of caspase-3 and H 2 O 2 reduces the activation 
of caspase-3. These observations suggest that ascorbylperoxide ef- 
fect on caspase-3 is through the death receptors [ 29 ]. From activation 
of these receptors until the ﬁnal endpoint of apoptosis: caspase-8 is 
ﬁrstly activated, followed by the activation of caspase-3 by caspase-8. 
The fact that the later is inhibited by H 2 O 2 [ 30 ] might explain the neg- 
ative effect of H 2 O 2 on caspase-3 activation, as found in our animal 
model. 
Levels of ascorbylperoxide in urine were lower in animals infused 
with solutions containing H 2 O 2 . These animals received intravenous 
solutions in similar amount to the ones who were infused with solu- 
tions devoid of H 2 O 2 . These ﬁndings suggest that animals receiving 
solutions containing H 2 O 2 had a better capacity to detoxify ascor- 
bylperoxide and that the concentration of ascorbylperoxide is impor- 
tant for the activation of caspase-3. The detoxiﬁcation of ascorbylper- 
oxide could be due to a higher activity of glutathione S-transferases, 
secondary to the greater activation of Nrf2 in the H 2 O 2 group. Further 
studies are needed to clarify the interactions between ascorbylper- 
oxide, Nrf2 activation, glutathione S-transferases and their effects on 
alveolar loss. 
Ascorbylperoxide is considered a xenobiotic due to its in vitro 
formation (in the parenteral nutrition solution) [ 17 ]. However, in an- 
imals infused with a solution devoid of ascorbylperoxide but contain- 
ing H 2 O 2 , the level of ascorbylperoxide is measurable in the urine 
( Fig. 1 ). This could be explained by the interaction between H 2 O 2 and 
dehydroascorbate, elements that are both present in the urine and 
are known to be precursor of ascorbylperoxide production [ 16 ]. The 
relation between the urinary concentrations of ascorbylperoxide in 
function of the quantity infused could be useful for a further clinical 
investigation on the impact of ascorbylperoxide on BPD development. 
Conclusion 
Ascorbylperoxide generated in parenteral nutrition appears to be 
related to the loss of alveoli associated to apoptosis induction. Al- 
though this molecule induces an increase of the redox potential, ﬁnd- 
ings of the current study suggest that this is a parallel phenomenon to 
apoptosis. Indeed, the shift in the redox potential toward a more oxi- 
dized status, as observed with ascorbylperoxide and with H 2 O 2 , is per- 
haps not sufﬁcient to induce apoptosis [ 18 ]. However, this modiﬁca- 
tion of the redox value should not be taken lightly. The increase of the 
redox potential obtained with ascorbylperoxide or H 2 O 2 could inﬂu- 
ence the proliferation and the differentiation of cells [ 18 ]. Pulmonary 
development, such as in premature newborns, must go through cel- 
lular proliferation, differentiation and apoptosis for the remodeling 
of the lungs, until they reach their ﬁnal maturity. Bronchopulmonary 
dysplasia may result from the perturbation of several of these cellular 
states. In our experimental model, we have exposed the association 
between the loss of alveoli, a feature of bronchopulmonary dysplasia, 
and ascorbylperoxide. The impact of ascorbylperoxide on other cel- 
lular stages and on the nature of the affected cells should be the focus 
of future investigations. Nevertheless, since the generation of ascor- 
bylperoxide is dependent on light exposure [ 17 ], the present study 
supports the beneﬁcial effect of photo-protection of parenteral nutri- 
tion on chronic lung disease [ 12 ], such as BPD [ 13 ] in neonates. Our 
results add an important piece of information regarding the mech- 
anism by which parenteral nutrition, as presently compounded, can 
induce BPD development. 
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